Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Nextleaf Solutions Ltd.

A pioneering force in the cannabis industry, driving innovation in extraction and life science technology.

 

Bullboard - Investor Discussion Forum Nextleaf Solutions Ltd C.OILS

Alternate Symbol(s):  OILFF

Healthcare Cannabis Health Care Cannabis
Nextleaf is a federally regulated manufacturer and distributor of cannabis vapes and oils under its prohibition-era brand, Glacial Gold. The Company’s multi-patented ingredient processing technology transforms cannabis and hemp biomass into high-purity distillate at an industrial scale. Nextleaf is a low-cost producer of cannabis oils, and supplies THC and CBD ingredients to partners across... see more

CSE:OILS - Post Discussion

Nextleaf Solutions Ltd > 119 million for 2021 the entire year 0.20 eps for 2021
View:
Post by Salbrom on Feb 28, 2021 6:00pm

119 million for 2021 the entire year 0.20 eps for 2021

So 28 million for this Q1 2021 0.05 eps for Tuesday or Monday wen ever it's released !!!
Comment by AuroraAurora on Feb 28, 2021 6:06pm
Salbrom: What a dangerous idiot you are. I want Nextleaf to succeed, but if you have these incredibly unrealistic expectations *which you portray as the truth,* then you're doing to singlehandedly mislead investors and Hurt Nextleaf when those false estimates don't pan out. What absolute garbage Salbrom. GTFO. 
Comment by Salbrom on Feb 28, 2021 6:30pm
These are not my numbers Ricky Martin go do a little research you'll find then online !!!! 
Comment by Gotime2 on Feb 28, 2021 6:17pm
COVID killed any IP licensing revenue. Deals are not always completed , bulk supply deals are turned into inventory not sales.  optomistic for $2 mil in sales
Nextleaf Solutions Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with C.OILS

Visit Facebook Visit X Visit Linked In Visit Instagram Visit Youtube


BRANDS HIGHLIGHTS & INSIGHTS EXTRACTION TECHNOLOGY SERVICES TEAM MEDIA VIRTUAL TOURS

Investor Presentation

View the Presentation

Investment Opportunity

  • Market Leadership with patented extraction and distillation technology offering significant efficiencies and higher purity levels over competing technologies
     
  • Debt free and four consecutive years of positive gross revenue. Reported fiscal YE 2023 gross revenue of $9.96MM with a gross profit of $2.3MM
     
  • Untapped domestic growth across various market segments, and the ability to scale production without additional capital expenditure
     
  • Backed by 19 U.S. patents and over 75 global patents provides a solid foundation for future growth and potential licensing opportunities

Nextleaf Solutions Ltd. With CEO, Emma Andrews

Primary Extraction

Distillation

Manufacturing: Softgels

The Vault

more...

Facebook

Contact Us